首页> 美国卫生研究院文献>Journal of Ginseng Research >Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity hepatic steatosis and insulin resistance in mice
【2h】

Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity hepatic steatosis and insulin resistance in mice

机译:人参加白虎汤可改善饮食引起的肥胖肝脂肪变性和胰岛素抵抗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dietary fat has been suggested to be the cause of various health issues. Obesity, hypertension, cardiovascular disease, diabetes, dyslipidemia, and kidney disease are known to be associated with a high-fat diet (HFD). Obesity and associated conditions, such as type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD), are currently a worldwide health problem. Few prospective pharmaceutical therapies that directly target NAFLD are available at present. A Traditional Chinese Medicine, ginseng-plus-Bai-Hu-Tang (GBHT), is widely used by diabetic patients to control glucose level or thirst. However, whether it has therapeutic effects on fat-induced hepatic steatosis and metabolic syndrome remains unclear.
机译:膳食脂肪被认为是导致各种健康问题的原因。肥胖,高血压,心血管疾病,糖尿病,血脂异常和肾脏疾病与高脂饮食(HFD)有关。肥胖和相关疾病,例如2型糖尿病和非酒精性脂肪肝疾病(NAFLD),目前是世界范围内的健康问题。目前,很少有直接针对NAFLD的前瞻性药物疗法。糖尿病患者广泛使用人参加白虎汤(GBHT)作为中药来控制血糖水平或口渴。但是,它是否对脂肪诱导的肝脂肪变性和代谢综合征具有治疗作用尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号